Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the † These two authors jointly supervised the work. Received: October 13, 2017. Revised: January 8, 2018. Accepted: January 9, 2018 
Introduction
Porphyria is a group of rare inherited metabolic disorders caused by dysfunctions of the heme biosynthesis pathway, leading to an accumulation of porphyrins or their precursors. Mutations of the gene encoding hydroxymethylbilane synthase (HMBS; HGNC: 4982), are associated with acute intermittent porphyria (AIP; MIM: #17600) the most frequent type of acute hepatic porphyria (1) . AIP is thought to display autosomal dominant inheritance with incomplete penetrance.
HMBS mutations are highly heterogeneous. About 400 different mutations of this gene have been reported worldwide. Missense mutations, non-sense mutations and mutations affecting splicing sites have been identified (2) . Many are family specific, but at least three mutations have been shown to be due to founder effects: p.Arg116Trp in the Netherlands (3), p.Trp198X (4) in Sweden and p.Trp238X in Switzerland (5) .
In the classical form of AIP, HMBS activity is about 50% lower than normal in all tissues. Factors increasing hepatic heme demand, resulting in an upregulation of hepatic aminolevulinate synthase (ALAS1) and enhancing the hepatic production of neurotoxic porphyrin precursors, delta amino levulinic acid (ALA) and porphobilinogen (PBG) that precipitate acute attacks. These trigger factors include hormonal fluctuations during the menstrual cycle, fasting, infections, stress and exposure to porphyrinogenic drugs (1) . Indeed, some drugs have been shown to induce ALAS1, either directly or indirectly, mainly through the induction of cytochrome P450 isoforms, and are known as porphyrinogenic.
Acute attacks are characterized by neurovisceral symptoms, such as abdominal pain, nausea, vomiting, sensory and motor neuropathy, and neuropsychiatric symptoms. Such attacks may be lethal if the correct treatment is not administered quickly. Most patients experience one to several attacks during their lifetime, but about 5% of patients in Europe (6) present with recurrent acute attacks with no identified precipitating factors and may, in rare cases, result in a need for liver transplantation (7) . The pathophysiological mechanism underlying this inter-individual variability is unknown.
In addition to acute crises, AIP patients also experience longterm comorbidities with higher than normal risk of hepatocellular carcinoma (8, 9) , renal impairment (10, 11) and hypertension (12, 13) .
In this study, we aimed to obtain further insight into the prevalence and penetrance of AIP and the contribution of genetic factors to the variable clinical expression of HMBS mutations.
We first calculated the penetrance of HMBS mutations in AIP patients in France. We then used the Exome Variant Server (EVS) database to estimate the prevalence of deleterious HMBS mutations in the general population and the penetrance of the AIP genetic trait.
Finally, we investigated further the genetic factors underlying the penetrance of AIP by analyzing genotype/phenotype correlations, and the pattern of familial correlations for the symptoms of the acute crises of AIP. We used these results to calculate the heritability of the disease.
Results

Prevalence of AIP in France and estimation of the penetrance of HMBS mutations in affected families
Considering the number of patients with active AIP referred to the French reference center was 500, we estimated the prevalence of overt AIP at 1 per 132 000 inhabitants in France (66.03 million inhabitants in 2015). Family trees, molecular and biochemical data were available for 253 families (see Materials and Methods). We identified 496 patients as symptomatic, and 1672 of their relatives as asymptomatic carriers of the HMBS mutation identified in the index case. We, therefore, estimated the penetrance of AIP in affected French families at 22.9% and 12.7% when excluding the probands.
Prevalence and penetrance of deleterious mutations of HMBS in the general population
We used the Exome Variant data as a surrogate for the general population.
In this database, we identified 127 nucleotide variants of HMBS in the 12 990 alleles from individuals of either Caucasian or African descent. These variants comprised 22 heterozygous missense mutations, 12 synonymous mutations, 11 untranslated regions (UTR) variants and 82 intron variants. No frameshift or non-sense alleles were found. Missense mutations were overrepresented in the general population relative to the population of French AIP patients (Fig. 1) , whereas the entire coding Figure 1 . Schematic representation of the percentage of HMBS missense variants identified in the EVS database or the CFP cohort. The entire coding sequence and the exon-intron junctions were both explored in both cohorts, although the sequencing of the exon-intron boundaries was limited to the border of the exons in the CFP database. No null allele was detected in the EVS database.
sequence and the junctions were both explored in both cohorts. To determine which of the 22 missense mutations were likely to be deleterious, we used HMBS expression in prokaryotes as the gold standard and evaluated whether bioinformatics tools could be a simple alternative for this assessment.
We selected 20 missense mutations from French families with AIP, for which pathogenicity was assessed in a pedigree study, accounting for 25% of the missense mutations observed in our cohort. HMBS defect was confirmed by a decrease of RBC HMBS activities in the 19 families for whom this result was available (Supplementary Material, Fig. S1 ).
Immunoblotting was performed with supernatants and pellets of HMBS-transfected bacteria to confirm that wild-type and mutated HMBS cDNA were expressed in similar amounts (Supplementary Material, Fig. S2) .
Then, for those 20 missense mutations, HMBS activity was measured (Table 1) . Interestingly, all the mutations tested presented little or no residual enzymatic activity, consistent with a strong deleterious effect of the mutation on HMBS activity.
Five HMBS mutants from EVS (p.Ala122Pro, p.Arg167Gln, p.Arg175Gln, p.Arg195Cys and p.Arg355Gln) encoded inactive proteins. Fifteen mutations including p.Glu86Val, p.Arg321His and p.Asp359Asn encoded proteins with residual enzymatic activities of more than 50% (Table 2 and Fig. 2) . Two variants had an intermediate enzymatic activity (p.Arg246Cys and p.Arg225Gln). We evaluated the heat and pH stability of these two variants. We found that p.Arg225Gln was sensitive to heat, displaying a strong decrease in enzymatic activity after 60 min (Fig. 3A) . None of the variants was abnormally sensitive to pH (Fig. 3B) .
Among the five variants with low HMBS residual activity, three were predicted to be 'probably damaging' with PolyPhen-2 and 'deleterious' with Provean (p.Ala122Pro, p.Arg167Gln and p.Arg195Cys). One was predicted to be 'neutral' with Provean and 'probably damaging' with PolyPhen-2 (p.Arg355Gln). One was predicted to be 'neutral' with Provean and 'benign' with PolyPhen-2 (p.Arg175Gln).
For the two variants with intermediate enzymatic activity, one exhibited conflicting results between softwares (p.Arg246Cys) and the second was predicted pathogenic by both softwares (p.Arg225Gln). The 15 other HMBS variants with normal residual HMBS activity were predicted to be 'deleterious' (Provean) and 'probably damaging' (PolyPhen-2) (5 HMBS variants), 'neutral', and 'benign' (8 HMBS variants) and two had conflicting results between programs. Altogether, these data highlight that the performances and mainly the specificity of these softwares are insufficient for accurate predictions of HMBS mutations pathogenicity.
Five of the variants in the EVS database had already been reported to be associated with AIP: p.Glu86Val, p.Arg167Gln, p.Arg195Cys, p.Arg321His and p.Asp359Asn (4, (14) (15) (16) (17) (18) . One of these mutations, p.Arg321His was predicted to be neutral by both Provean and Polyphen-2, whereas Provean predicted p.Glu86Val and p.Asp359Asn to be neutral. By contrast, two variants (p.Arg167Gln and p.Arg195Cys) were classified as deleterious by both programs.
Considering the five HMBS variants from the EVS (p.Ala122Pro, p.Arg167Gln, p.Arg175Gln, p.Arg195Cys and p.Arg355Gln) with undetectable activities and taking their respective frequencies into account in the prevalence calculation, we obtained a minimal prevalence of pathogenic HMBS mutations in the general population of 1/1299. The addition of p.Arg225Gln in this calculation, based on its heat sensitivity, resulted in a higher estimated prevalence of 1/650.
We estimated the prevalence of pathogenic AIP mutations in France as between 50 000 to 100 000 subjects and the penetrance of HMBS mutations in the general population as 0.5-1%.
Intra-familial correlations and heritability in AIP families
We estimated the pattern of phenotypic correlations among pairs of relatives, including 974 pairs of siblings, 1187 parent-offspring Mutations are indicated in both the c.DNA and protein sequences. Results of Provean and PolyPhen-2 predictions concerning the pathogenicity are mentioned.
The percentage of residual activity is expressed as a ratio between the variant and the wild-type HMBS activities.
When available, previous publications are listed. pairs, 575 grandparent-grandchild pairs, 1462 aunt/unclenephew/niece pairs and 824 pairs of cousins. A significant positive correlation was found between siblings; there was no correlation between parents and offspring. Significant negative correlations were found between second-degree relatives, grandparents and grandchildren, and uncles/aunts and their nieces/ nephews (Table 3A) . We suggested that these contra-intuitive negative correlations might be related to the bias introduced by the selection of AIP families with at least one overt patient, ignoring the vast majority of asymptomatic AIP families. Whatever their familial links, these initial correlations resulted in a significant loss of convergent pairs of asymptomatic relatives, artificially decreasing the correlation estimates. Based on the penetrance of HMBS mutations in the general population, and considering that these undiagnosed asymptomatic AIP families would have statistically similar familial structures to symptomatic AIP families, we estimated the actual number of pairs of relatives and the intra-familial correlations (see Materials and Methods). Correlations ranged from 10.4% between grandparents and grandchildren and 36.6% between siblings (Table 3B) . We then represented the respective weight of the different factors influencing intra-familial correlations, i.e. the degree of kinship and generation reflecting the shared environment (Fig. 4) . Finally, we calculated AIP heritability in affected families, resulting in an estimate of 58% (parent-offspring) to 73% (siblings).
Genotype-phenotype correlation
Finally, we evaluated the respective frequencies of missense mutations and null alleles in patients from simplex (n ¼ 106) and multiplex families (n ¼ 147), in those with recurrent forms (n ¼ 37) and individuals from the EVS database (n ¼ 6495). Null alleles, leading to a complete loss of function of the protein, were more frequent in multiplex families than in simplex families (v 2 1 df: 5.393, P ¼ 0.03) and tended to be more common in recurrent forms than in less severe forms, although the difference was not statistically significant. Null alleles accounted for almost 80% of the variants observed in multiplex forms but were absent in individuals from the EVS database (Figs 1 and 5 ).
Discussion
The objective of this study was to unravel the transmission and phenotypic expression of AIP. We began by evaluating the pathogenicity of 42 HMBS missense variants identified in families with AIP (n ¼ 20) and the EVS database (n ¼ 22).
Taking into account pathogenic mutations as those leading to proteins with less than 15% residual HMBS activity in vitro, as observed in the AIP families from the CFP, only five of the mutations in the EVS database could be considered pathogenic. As evidenced in Figure 2 , some EVS variants exhibited HMBS activities higher than the wild-type cDNA, suggesting the possible existence of some trans-acting genetic modifiers that could be protective against AIP.
Five missense variants identified in EVS had already been published as causing AIP, and only two of them were associated with a low residual level of HMBS activity in vitro. The other three variants had a relatively high prevalence in the EVS database, suggesting they could be rare polymorphisms. The p.Glu86Val variant resulted in no visible defect of HMBS activity in red blood cells (RBC) (4). The p.Arg321His variant had almost normal levels of HMBS activity in RBC (17) . Finally, no clinical or biological data were available for the p.Asp359Asn variant. Three other variants may potentially modify splicing sites. Considering pathogenic mutations as those leading to proteins with less than 15% residual HMBS activity in vitro, as observed in the AIP families, five of the mutations in the EVS database can be considered pathogenic.
If five mutations of EVS are considered as pathogenic, this will result in the general population in a minimal prevalence of the genetic trait for AIP of 1/1299. The inclusion of the p.Arg255Gln variant with poor thermostability and initially described by (20) . Thus, 50 000-100 000 subjects are likely to have HMBS mutations in France.
As a consequence, the penetrance of the disease in the general population is estimated at 0.5-1% (considering 500 the number of patients with active AIP referred to the CFP at the moment) consistent with the very low incidence of AIP in France (0.12 new case per year per million inhabitants). This calculation contrasts with the 12.7% penetrance measured in the relatives of AIP index cases highlighting a robust familial aggregation. The contribution of additional transmitted factors, either genetic or environmental, to the triggering of acute symptoms in families with AIP, is thus likely. Penetrance in AIP has been shown to be affected by sex, age (17) and precipitating factors, particularly environmental factors, such as fasting, alcohol intake, hormones, infections, pollutants and the consumption of porphyrinogenic drugs. On the other hand, null alleles were significantly more frequent in familial AIP than in apparently sporadic AIP and tended to be more frequent in patients with recurrent forms of AIP. The apparent discrepancy between the frequencies of null alleles and missense mutations in AIP families (74% and 26%, respectively) and the general population (0% and 100%, respectively) suggests that haplo-insufficiency is an important triggering factor affecting penetrance. Altogether, this genotype-phenotype correlation indicates that the most severe and penetrant genotypes involve null alleles (21) . For the study of intra-familial phenotypic correlations, the distribution of HMBS mutations and AIP phenotypes was extrapolated to the total The familial links were classified as follow: first degree (sibling and parent-off-spring), second degree (grandparents-grandchildren and uncle/aunt-nephew and niece) and third degree (cousins).
In Table 3A , the number of pairs coming from the CFP pedigree and included into the calculation of person product-moment correlation coefficient R as indicated in the Materials and Methods section. This first approach led to some negative correlations in second-degree relatives.
This observation prompted us to estimate d*, the number of asymptomatic pairs of relatives, as follows
ÞþdK and to calculate the person product moment correlation coefficient R(a, b, c, d*). Assuming that penetrance was at 1%, the calculated coefficient of correlation is presented in Table 3B . We thus concluded that correlation declines with the genetic distance.
French population, to obtain unbiased estimates. In families, the correlation decreased globally from first-to third-degree relatives, suggesting that additional genetic factors independent of HMBS locus influence the outcome of the disease (i.e. correlation coefficient would be independent of kinship if the HMBS locus was the main determinant of AIP symptoms). We also noted a generational effect: at the same level of kinship, correlations were found to be higher for those living over the same period of time than between different generations. The correlation decreased with the number of generations (brothers/sisters versus parents/offspring, or uncles/nephews versus grandparents/grandchildren) highlighting the effect of the environment. This result might be expected because peoples living during the same period are likely to share more environmental factors, such as diet, and exposure of xenobiotics (see above). By contrast, for pairs of the same generation but with different kinship, correlations decrease when kinship increase (brothers/sisters versus cousins and parents/ offspring versus uncle/aunt-nephew/niece) highlighting the effect of genetic factors (for closer kinship, subjects share more genetic factors by descent). All these observations show that genetic factors (linked or not to HMBS), as well as shared environmental factors, modulate the risk of having AIP attacks in carriers of deleterious HMBS mutations. We can speculate that genes involved in xenobiotic detoxification, such as the cytochrome P450 hemoproteins, or in the heme biosynthesis pathway, contribute to this heritability (17) . ALAS1 expression, which increases sharply during acute crises of AIP could be genetically governed. Heme oxygenase 1 (HO-1) , the principal inducible enzyme involved in heme catabolism in the liver, may also play a role. Indeed, a functional length polymorphism of (GT)n repeats in the HMOX1 promoter (22) influencing HO-1 levels has been identified. Transient-transfection assays have shown that smaller numbers of (GT)n repeats are associated with much higher levels of transcription for this gene (23) (24) (25) . Further studies are required to evaluate their impact on the clinical expression of AIP.
As a consequence, AIP transmission seems to be more complicated than initially thought. AIP transmission did not follow the pattern typical of autosomal dominant diseases. Instead, a careful analysis of AIP family pedigrees suggests that an oligogenic inheritance model, profoundly modified by environmental factors, could explain the familial aggregation in AIP.
The prevention policy of acute attacks should integrate our present observations. Indeed, the high estimate of heritability highlights the importance of performing family studies and delivering therapeutic education. In our opinion, due to the 0.5-1% penetrance of HMBS mutations in the general population, the discovery of an HMBS mutation without familial history justifies only the provision of information about AIP prodromes and symptoms.
To conclude, using functional studies, the minimal estimated prevalence of AIP in the general population is high (1/1299), and its penetrance is extremely low (0.5-1%), precluding population studies to identify asymptomatic carriers of AIP. Loss-of-function mutations are associated with a more severe phenotype and a higher penetrance than other types of mutations. Heritability appears to be quite high in French families with AIP and probably in most other countries justifying familial studies. All these new data must be taken into account, to develop better strategies for preventing severe acute crises of porphyria in both families with AIP and the general population.
Indeed, the presence of a demonstrated pathogenic HMBS mutation is an essential condition for the occurrence of AIP, but penetrance seems to be firmly controlled by additional yet unidentified genetic and environmental factors. The oligogenic model of inheritance with environmental modifiers postulated from the present study could only be tested in segregation studies in a broader international study to include the highest number of AIP families and twin pairs available from as many countries as possible.
Materials and Methods
Subjects
Between the creation of the CFP in 1974 and 2016, 602 AIP patients with at least one acute attack were diagnosed. The porphyrin profiles of urine, feces and plasma samples were used to exclude differential diagnoses. Either HMBS deficiency in RBC (26) and/or the identification of a potentially pathogenic variant of HMBS were used to confirm the diagnosis. Increased ALA and PBG levels of 10-fold or more, associated with acute neurovisceral symptoms, confirmed the diagnosis of an acute attack. Thirty-six of the patients in the cohort had recurrent attacks, defined as at least four acute attacks per year (EPNET definition).
Among the cohort of 602 patients:
• 212 were unrelated, 106 came from a simplex family and 106 had no available familial data and were therefore excluded from the penetrance and heritability study • 390 came from 147 multiplex families with two to six members with at least one acute attack.
Most of the patients were of Caucasian origin.
Within the AIP families, we identified 1968 relatives carrying a genetic mutation associated with AIP. All procedures were performed according to the 1983 and 2008 revisions of the Declaration of Helsinki, and the study was approved by the institutional review board and ethics committee of Bichat University Hospital. All patients gave informed consent for participation. (27) and Provean (Protein Variation Effect Analyzer) (28) . Polyphen-2 assesses the impact of an amino-acid substitution on the sequence and structure of the protein and phylogeny, whereas Provean is based on pairwise sequence alignment scores.
EVS analysis and in silico prediction of the functional impact of HMBS variants
Intrafamilial correlation for acute crises in AIP
We calculated the Pearson product moment correlation coefficient for the occurrence of neurovisceral acute crises. For a given familial link, a, b, c and d are the number of symptomatic/symptomatic, symptomatic/asymptomatic, asymptomatic/symptomatic and asymptomatic/asymptomatic pairs of relatives with a pathogenic mutation, respectively. We define p1 and p2 as the observed penetrance of acute neurovisceral crises among the first and second members of the pairs of relatives, respectively. Pearson's correlation coefficient was calculated as follows:
Given the low penetrance of AIP, we were unable to recruit many of the families with pathogenic HMBS mutations (as their members were asymptomatic). This incapacity would have resulted in the loss of many convergent pairs of asymptomatic relatives (d). Assuming that asymptomatic families have a similar structure to families with at least one symptomatic member, the number d* of asymptomatic pairs of relatives that would have been enrolled if these asymptomatic families had been identified can be estimated as follows:
With K being the ratio of penetrance in the recruited families to that in the general population. The real intra-familial correlation in the occurrence of acute crises between relatives in AIP families would, therefore, be given by R(a, b, c, d*), for each familial link.
This method was validated by randomly generating 8000 three-generation families. Each family was assigned a score out of 100 to reflect the influence of genome and environment. For grandparents, this score was a random integer, uniformly distributed between 1 and 100. For the second and the third generations, the score was calculated as 0.33M þ 0.33F þ E, where M and F are the parental scores, and E is a random integer uniformly distributed between 1 and 34. Scores above 80 were considered to be pathogenic. Within these randomly generated families, all correlations were found to be positive and to decrease with increasing distance of the relationship. Moreover, if we restricted the analysis to only families with at least one symptomatic member, we obtained correlations similar to those observed in real families. The extrapolation method described above made it possible to recover the correlation between all generated families with a high level of precision (to within 0.01), using only data for symptomatic families and the penetrance ratio K. This validates our model.
Estimation of heritability
As previously described (29) , heritability was estimated with Falconer's formula (30) , as twice the rate of phenotypic correlation between siblings or between parents and offspring after correction.
Expression of HMBS variants in Escherichia coli
We expressed all the EVS variants and the 20 most frequent mutants of the 94 identified in AIP families in E. coli.
Variants identified in the EVS database were introduced by site-directed mutagenesis with the Quikchange kit (Stratagene, La Jolla, CA) into pET101 containing the wild-type human HMBS c.DNA, according to the manufacturer's instructions. The coding sequence of the resulting c.DNAs (Ref: NM_000190.3) was sequenced as described previously (2) . These variants were then transferred into E. coli BL21 DE3 (Invitrogen, Life Technologies) as recommended by the manufacturer.
Enzymatic activity and stability of recombinant HMBS
We assessed the HMBS activity of control and mutant enzymes in crude bacterial lysates, using a slightly modified version of apublished procedure (2) . Frozen cell pellets were suspended in 500 mL of lysis buffer (1% Tween in 150 mM Tris-HCl and 1 mM ethylene diamine tetra acetate pH 8.0), and subjected to three rounds of sonication on ice. The lysate was centrifuged for 5 min, the supernatant was diluted four-fold in lysis buffer, and total protein concentration was adjusted to obtain final protein concentrations of 0.01-0.5 mg/mL. We dispensed 200 mL of 100 mM Tris-HCl, pH 8.0 and 200 mL enzyme extract, incubated 5 min at 37 C, and added 25 mL of 1 mM PBG. After 1 h at 37 C, we added 1.6 mL of 10% (w/v) trichloracetic acid. Samples were incubated on ice for 10 min, centrifuged for 10 min at 18 500g and uroporphyrin was quantified in supernatants in a Varian Cary Eclipse spectrofluorometer fitted with a red-sensitive photomultiplier (excitation at 405 nm, emission at 655 nm 
Genotype/phenotype correlation
We determined the respective frequency of both missense mutations and 'null' alleles (including large insertion or deletions, mutations resulting in truncated proteins and splicing mutations) in the patients from EVS and those from AIP families.
Statistical analysis
Mann-Whitney tests were used to compare the residual activity of the recombinant HMBS between groups. v 2 analysis with 1 df was performed to compare the frequencies of missense mutations and null alleles, with Yates' correction if required. GraphPad Prism 6 (GraphPad software) and Excel (Microsoft) were used for statistical analysis and the plotting of graphs.
Supplementary Material
Supplementary Material is available at HMG online.
